Press Releases

May 6, 2019 -- Glucose Health, Inc. Raises $460,000 from Angel Investors; Eliminates Dilutive Convertible Debt Security, Benefitting All Shareholders.

BENTONVILLE AR – Glucose Health, Inc. (OTC: “GLUC” “Company”) has raised $460,000 from a group which includes sophisticated beverage industry angel investors. A portion of the $460,000 investment proceeds, received in the Company’s bank account last week, was immediately deployed for full and final payment of a $165,365 dilutive “convertible to equity” debt security, which originated from convertible promissory note financings entered into by GLUC, beginning in fiscal year 2013.  
CEO Murray Fleming stated, “sophisticated beverage industry

Read more

April 1, 2019 -- Glucose Health, Inc. ANNUAL REPORT – Revenue Up 89%, Gross Profit Up 17%, Expenses Down 27%.

BENTONVILLE AR – Glucose Health, Inc. (OTC: “GLUC”) confirms the following selected financial data from its ANNUAL REPORT for the fiscal year ended December 31, 2018, posted today on
Fiscal year ended December 31, 2018:
  1. Fiscal 2018 Revenue of $197,500 compared with $104,522 for Fiscal 2017; an increase of 89%.
  2. Fiscal 2018 Gross Profit of $52,818 compared with $45,112 for Fiscal 2017; an increase of 17%.
  3. Total Operating Expenses of $76,304 vs. $104,522 for Fiscal 2017;
  4. ...

Read more

March 19, 2019 -- WALMART GLUCODOWN® Sales Increase 27% YTD

BENTONVILLE AR – New sales statistics show GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: GLUC) (“Company”), is benefiting from increasing consumer awareness, early in 2019. Sales of GLUCODOWN® at Walmart pharmacies are up 27% for the first seven weeks of 2019 vs. the first seven weeks of 2018. Even more impressive is the 27% sales increase in 2019 is measured against a Walmart price “Rollback” in the same period of 2018 (which began the liquidation of the first generation of GLUCODOWN®).  Glucose Health, Inc. expects Walmart sales of GLUCODOWN® to continue to increase

Read more



GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: GLUC) (“Company”), is not only generating impressive sales growth on Amazon; its winning the battle vs. long-established brands in the diabetic nutritional category, including from manufacturers SlimFast, Abbott Labs and Nestle. GLUCODOWN®, in its first 4-week period of Amazon availability (October-November 2018), generated revenues of $5,907 from 464 containers sold.  In the latest 4-week period (February-March 2019),...

Read more